Website profile

Pharmadispatch

News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals

  • 32articles · 30d
  • 2+ day agolatest article
  • Aug 17, 2026earliest in window
  • 91%with images
  • 135avg words
articles per day
Categories
  • Medical 30
  • Health 23
  • Health & Wellness 23
  • Business & Industrial 9
  • Science & Technology 4
  • Economy, Business & Finance 3
  • Finance & Business 2
  • Human Interest 1

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
pharmadispatch.com > news > entropy-takes-trp-8803-to-the-us-in-head-to-head-depression-trial

Entropy takes TRP-8803 to the US in head-to-head depression trial - BioPharmaDispatch

2+ week, 3+ day ago   (143+ words) Entropy takes TRP-8803 to the US in head-to-head depression trial PharmaDispatch Entropy takes TRP-8803 to the US in head-to-head depression trial Entropy Neurodynamics has signed an agreement with the University of California, San Francisco, to develop a US Phase 2 trial…...